Complete Bibliography

Visit PubMed to view Dr. Larry Corey's full publication record.

Larry Corey
Larry Corey of the CoVPN Fred Hutch


A blog series discussing the evolving science and policy of COVID-19 vaccines, led by internationally renowned experts in vaccine development, Dr. Larry Corey of the Univeristy of Washington/Fred Hutch, and Dr. Chris Beyrer of Johns Hopkins University.

Select Recent Publications (selected from over 750)


Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021 Feb 4;384(5):403-416.


Haeseleer F, Eichholz K, Tareen SU, Iwamoto N, Roederer M, Kirchhoff F, Park H, Okoye AA, Corey L. Real-Time Killing Assays to Assess the Potency of a New Anti-Simian Immunodeficiency Virus Chimeric Antigen Receptor T Cell. AIDS Res Hum Retroviruses. 2020 Dec;36(12):998-1009.

McLaughlin CC, Doll MK, Morrison KT, McLaughlin WL, O'Connor T, Sholukh AM, Bossard EL, Phasouk K, Ford ES, Diem K, Klock AM, Jerome KR, Corey L. High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results. medRxiv. 2020 Jul 21:2020.07.19.20157198.

Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science. 2020 May 29;368(6494):948-950.

Randhawa AK, Fisher LH, Greninger AL, Li SS, Andriesen J, Corey L, Jerome KR. Changes in SARS-CoV-2 Positivity Rate in Outpatients in Seattle and Washington State, March 1-April 16, 2020. JAMA. 2020 Jun 9;323(22):2334-2336. 

Hosseinipour MC, Innes C, Naidoo S, Mann P, Hutter J, Ramjee G, Sebe M, Maganga L, Herce ME, deCamp AC, Marshall K, Dintwe O, Andersen-Nissen E, Tomaras GD, Mkhize N, Morris L, Jensen R, Miner MD, Pantaleo G, Ding S, Van Der Meeren O, Barnett SW, McElrath MJ, Corey L, Kublin JG. Phase 1 HIV vaccine trial to evaluate the safety and immunogenicity of HIV subtype C DNA and MF59-adjuvanted subtype C Env protein. Clin Infect Dis. 2020 Jan 4. pii: ciz1239. 


Gray GE, Huang Y, Grunenberg N, Laher F, Roux S, Andersen-Nissen E, De Rosa SC, Flach B, Randhawa AK, Jensen R, Swann EM, Bekker LG, Innes C, Lazarus E, Morris L, Mkhize NN, Ferrari G, Montefiori DC, Shen X, Sawant S, Yates N, Hural J, Isaacs A, Phogat S, DiazGranados CA, Lee C, Sinangil F, Michael NL, Robb ML, Kublin JG, Gilbert PB, McElrath MJ, Tomaras GD, Corey L. Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa. Sci Transl Med. 2019 Sep 18;11(510).

Li AZ, Corey L, Zhu J. Random-Reaction-Seed Method for Automated Identification of Neurite Elongation and Branching. Sci Rep. 2019 Feb 27;9(1):2908.

Lo M, Zhu J, Hansen SG, Carroll T, Farr Zuend C, Nöel-Romas L, Ma ZM, Fritts L, Huang ML, Sun S, Huang Y, Koelle DM, Picker LJ, Burgener A, Corey L, Miller CJ. Acute Infection and Subsequent Subclinical Reactivation of Herpes Simplex Virus 2 after Vaginal Inoculation of Rhesus Macaques. J Virol. 2019 Jan 4;93(2).


Ford ES, Magaret AS, Spak CW, Selke S, Kuntz S, Corey L, Wald A. Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected persons. AIDS. 2018 Nov 13;32(17):2525-2531.

Agyemang E, Magaret AS, Selke S, Johnston C, Corey L, Wald A. Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of AntiviralsJ Infect Dis. 2018 Oct 20;218(11):1691-1699.


Peng T, Chanthaphavong RS, Sun S, Trigilio JA, Phasouk K, Jin L, Layton ED, Li AZ, Correnti CE, De van der Schueren W, Vazquez J, O'Day DR, Glass IA, Knipe DM, Wald A, Corey L, Zhu J. Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation. J Exp Med. 2017 Aug 7;214(8):2315-2329. 

Corey L, Gray GE. Preventing acquisition of HIV is the only path to an AIDS-free generationProc Natl Acad Sci U S A. 2017 Apr 11;114(15):3798-3800.

Posavad CM, Zhao L, Dong L, Jin L, Stevens CE, Magaret AS, Johnston C, Wald A, Zhu J, Corey L, Koelle DM. Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tractMucosal Immunol. 2017 Sep;10(5):1259-1269.  


Wald A, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Fife K, Selke S, Huang ML, Stobernack HP, Zimmermann H, Corey L, Birkmann A, Ruebsamen-Schaeff H. Effect of pritelivir compared with valacyclovir on genital HSV-2 shedding in patients with frequent recurrences: a randomized clinical trialJAMA. 2016 Dec 20;316(23):2495-2503.

Milman N, Zhu J, Johnston C, Cheng A, Magaret A, Koelle DM, Huang ML, Jin L, Klock A, Layton ED, Corey L. In situ detection of regulatory T cells in human genital HSV-2 reactivation and their influence on spontaneous HSV-2 reactivationJ Infect Dis. 2016 Jul 1;214(1):23-31.


Corey L, Gilbert P, Tomaras GD, Haynes BF, Pantaleo G, Fauci AS. Immune Correlates of Vaccine Protection Against HIV-1 Acquisition: A ReviewSci Transl Med. 2015 Oct 21;7(310):310rv7.
Reprint | Full Text

Christine M. Posavad, Lin Zhao, Dawn E. Mueller, Claire E. Stevens, Meei Li Huang, Anna Wald and Lawrence Corey. Persistence of mucosal T cell responses to herpes simplex virus type 2 (HSV-2) in the female genital tractMucosal Immun. 2015 Jan;8(1):115-26. PMC4263695 

Earlier work (2009-2014)

Johnston C, Zhu J, Jing L, Laing K, McClurkan  C, Klock A, Diem K, Stanaway J, Tronstein E, Kwok WW, Huang ML, Selke S, Fong Y, Magaret A, Koelle DM, Wald A, and Corey L. Virologic and immunologic evidence of multifocal genital herpes simplex virus type 2 infectionJ Virol. 2014 May;88(9):4921-31.

Schiffer JT and Corey L. Rapid host immune response and viral dynamics in herpes simplex virus-2 infection. Nat Med. 2013 Mar 6;19(3):280-8. NIHMSID559213

Schiffer JT, Swan D, Al Sallaq R, Magaret A, Johnston C, Mark KE, Selke S, Obemichael N, Kuntz S, Zhu J, Robinson B, Huang ML, Jerome KR, Wald A, Corey L. Rapid Localized Spread and Immunologic Containment of Herpes Simplex Virus-2 in the Human Genital TracteLife. 2013;2:e00288.

Zhu J, Peng T, Johnston C, Phasouk K, Kask AS, Klock A, Jin L, Diem K, Koelle DM, Wald A, Robins H, Corey L. Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infectionNature. 2013 May 23;497(7450):494-7.

Johnston C, Saracino M, Kuntz S, Magaret A, Selke S, Huang ML, Schiffer JT, Koelle DM, Corey L, Wald A. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomized, open-label cross-over trialsLancet. 2012 Feb 18;379(9816):641-7. PMC3420069

Peng T, Zhu J, Phasouk K, Koelle D, Wald A and Corey L. An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of HSV-2 infection. J Virol. 2012 Oct;86(19):10587-96. PMC3457322

Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Koelle DM, Wald A, Corey L. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodesProc Natl Acad Sci U S A. 2010 Nov 2;107(44):18973-8. PMC2973882

Peng T, Zhu J, Klock A, Phasouk K, Huang ML, Koelle DM, Wald A, Corey L. Evasion of the mucosal innate immune system by herpes simplex virus type 2J Virol. 2009 Dec;83(23):12559-68. PMC2786730

Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Magaret A, Wald A, Corey L. Frequent Release of Low Amounts of Herpes Simplex Virus From Neurons: Results of a Mathematical ModelSci Transl Med. 2009 Nov 1;1(7):7ra16. PMC2818652

Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, Remington M, Magaret A, Koelle DM, Wald A, Corey L. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisitionNat Med. 2009 Aug; 15(8):886-92. PMC2723183